-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

112. Thalassemia and Globin Gene Regulation: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, Biological, sickle cell disease, Diseases, Non-Biological, Combinations, thalassemia, Therapies, cellular interactions, Biological Processes, Hemoglobinopathies, gene therapy, Technology and Procedures, erythropoiesis, gene editing, Study Population, Clinically relevant, pharmacology, iron metabolism, pathways
Monday, December 7, 2020: 7:00 AM-3:30 PM

Kevin H.M. Kuo, MD, MSc, FRCPC1, D. Mark Layton, MB BS2*, Ashutosh Lal, MD3, Hanny Al-Samkari, MD4, Feng Tai, PhD5*, Megan Lynch, MSN5*, Katrin Uhlig, MD5* and Elliott P. Vichinsky, MD3

1University Health Network, Toronto, ON, Canada
2Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
3UCSF Benioff Children's Hospital Oakland, Oakland, CA
4Division of Hematology, Massachusetts General Hospital, Dana-Farber Cancer Institute, Harvard University, Boston, MA
5Agios Pharmaceuticals, Inc., Cambridge, MA

Georgia L. Gregory, BS1,2,3*, Beeke Wienert, PhD3*, Marisa Schwab, MD1,4*, Billie Rachael Lianoglou, MS1,4*, Roger P. Hollis, PhD5*, Donald B. Kohn, MD6, Bruce R. Conklin, MD3,7,8* and Tippi C. MacKenzie, MD1,4,9

1Department of Surgery, UCSF, San Francisco, CA
2Institute of Human Genetics, UCSF, San Francisco, CA
3Gladstone Institutes, UCSF, San Francisco, CA
4Center for Maternal-Fetal Precision Medicine, UCSF, San Francisco, CA
5Broad Stem Cell Research Center, UCLA, Los Angeles, CA
6Broad Stem Cell Research Center, University of California - Los Angeles, Los Angeles, CA
7Innovative Genomics Institute, UCB, Berkeley, CA
8Departments of Medicine, Ophthalmology, and Pharmacology, UCSF, San Francisco, CA
9Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, UCSF, San Francisco, CA

Chang Li1*, Sucheol Gil2*, Kevin A. Goncalves, PhD3*, John C. Davis Jr., MD, MPH, MS3*, Hans-Peter Kiem, MD PhD4 and Andre Lieber, MD, PhD2

1Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA
2University of Washington, Seattle, WA
3Magenta Therapeutics, Cambridge, MA
4Fred Hutchinson Cancer Research Center, Seattle, WA

Vinzon Ibanez, B.S.1,2*, Kestis Vaitkus2*, Robert E. Molokie, MD3,4, Yogenthiran Saunthararajah, MD5,6 and Donald Lavelle, PhD2,7

1Department of Medicine, University of Illinois Chicago, chicago
2Department of Medicine, University of Illinois at Chicago, Jesse Brown VA Medical Center, Chicago, IL
3Jesse Brown VA Medical Center, Chicago, IL
4Department of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
5Department of Translational Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL

Christopher C Denton, MD1*, Payal Shah, MS1*, Silvie Suriany, MS2*, Honglei Liu, MS2*, Wanwara Thuptimdang, MS3*, John Sunwoo, PhD3,4*, Patjanaporn Chalacheva, PhD3,5*, Saranya Veluswamy, MD1*, Roberta Miyeko Kato, MD6*, John C Wood, MD, PhD2*, Jon A Detterich, MD2*, Michael C.K. Khoo, PhD3* and Thomas D. Coates, MD1

1Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, CA
2Cardiology, Children's Hospital Los Angeles, Los Angeles, CA
3Biomedical Engineering, University of Southern California, Los Angeles, CA
4Athinoula A. Martinos Center for Biomedical Engineering, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA
5Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA
6Pulmonology, Children's Hospital Los Angeles, Los Angeles, CA

Laura Grech, PhD, MSc, B.Sc1*, Joseph Borg, PhD, MSc, BSc2, Ruth Galdies, M.Sc BPharm1,3*, Carmen Attard3*, Christian A. Scerri, MD, PhD1,3*, Sjaak Philipsen, PhD4* and Alexander E. Felice1,3

1Thalassemia Testing and Hemoglobin Research Laboratory, and The Malta Bio-Bank, Department of Physiology and Biochemistry, University of Malta, Msida, Malta
2Department of Applied Biomedical Science, Faculty of Health Sciences, Mater Dei Hospital, Birkirkara, Malta
3Division of Pathology, Thalassemia and Genetics Clinic, Mater Dei Hospital, Msida, Malta
4Department of Cell Biology, Erasmus MC, Rotterdam, Netherlands

Heinrich E Lob, PhD, Leah Kravets, B.S.*, Lawrence Miloscio, BS*, Jason Mastaitis, PhD*, Aris N Economides, PhD* and Sarah J Hatsell, PhD*

Regeneron Pharmaceuticals, Inc., Tarrytown, NY

Xiaoqing Jia1*, Qi Yao2*, Hui Li3* and Jieping Chen4*

1Southwest Hospital,Third Military Medical University(Army Medical University), Chongqing, China
2Southwest Hospital,Third Military Medical University (Army Medical University), Chongqing, China
3Southwest Hospital,Third Military Medical University, Chongqing, China
4Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China

*signifies non-member of ASH